OTSU Pharmaceuticals: Major
Health Technology
Mkt Cap
4.4B
P/E (TTM)
9.24
EPS
39.02
ROE
50.84%
Div Yield
—
About
Otsuka Pakistan Ltd. engages in the manufacturing, marketing, and distribution of intravenous infusions, pharmaceutical products, nutritional foods, and medical equipment. It offers electrolytes solutions, carbohydrates solutions, clinical nutrition, medical devices, and therapeutic drugs. The company was founded in February 1988 and is headquartered in Karachi, Pakistan.
Financial Highlights
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | ||
|---|---|---|---|---|---|---|
| Revenue | 4.11B | 3.78B | 3.16B | 3.05B | 2.85B | |
| Gross Profit | 1.46B | 833.27M | 559.16M | 645.83M | 893.58M | |
| Net Income | 472.13M | 27.68M | -4.76M | -7.21M | 231.80M | |
| EPS | 39.02 | 2.29 | -0.39 | -0.60 | 19.16 | |
| ROE | 50.86% | 4.04% | -0.69% | -1.02% | 38.19% | |
| ROA | 16.95% | 1.14% | -0.21% | -0.35% | 13.92% | |
| Gross Margin | 35.49% | 22.05% | 17.68% | 21.17% | 31.33% | |
| Net Margin | 11.48% | 0.73% | -0.15% | -0.24% | 8.13% | |
| Current Ratio | 1.23 | 0.99 | 1.07 | 1.10 | 1.31 | |
| DPS | 0.00 | 0.00 | 0.00 | 1.50 | 1.50 | |
| Free Cash Flow | 163.86M | 85.30M | 210.54M | -376.35M | -39.05M |